These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Molecular mechanisms of fibrinolysis and perspectives of thrombolytic therapy]. Veremeenko KN, Kizim AI. Vopr Med Khim; 1984; 30(5):13-22. PubMed ID: 6084892 [Abstract] [Full Text] [Related]
4. [Antiplasmin and its effect on the process of fibrinolysis in experiments]. Kudriashov BA, Pastorova VE. Biull Eksp Biol Med; 1966 Feb; 61(2):40-2. PubMed ID: 4235805 [No Abstract] [Full Text] [Related]
15. [FIBRINOLYSIS INHIBITORS AND DETERMINATION OF PHYSIOLOGICAL AND PATHOLOGICAL ANTIPLASMIN ACTIVITY]. MORIAU M, DE VRIES SI, DIK HJ. Thromb Diath Haemorrh; 1964 Jan 01; 10():355-78. PubMed ID: 14113376 [No Abstract] [Full Text] [Related]
16. [Method for the determination of fibrinolytic activity of plasma euglobulin fraction and of antifibrinolytic activity of blood serum]. Aslanian NL, Shukhian VM. Lab Delo; 1971 Jan 01; 6():329-31. PubMed ID: 4108742 [No Abstract] [Full Text] [Related]